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A
mEditorial
Critical care is a rapidly growing specialty. As a mark of its increasing maturity and
health, its practitioners are increasingly challenging long-held dogma and revising
practice guidelines. Critical care certainly punches well beyond its weight, accounting
for a disproportionately large number of clinical trials reported in the highest impact
factor journals. An impressive level of altruistic collaboration has often driven such
studies, even on shoestring budgets. Outcomes have improved, in large part due to
improvements in general care, early recognition of deterioration, and avoidance of
iatrogenic harm.
Notwithstanding these achievements, few novel drugs or other interventions that
have impacted positively on patient outcomes have come to the fore over the last 20 to
30 years. This disconnect highlights the crucial disparity between the clinical and bio-
logical phenotypes of critical illness. Treatment strategies based on clinical syndromic
presentations, e.g. for sepsis, acute respiratory distress syndrome, and acute kidney
injury, have repeatedly fallen short of their initial promise. The heterogeneity of the
population with respect to age, gender, underlying comorbidity, trajectory and severity
of illness, time to presentation, infecting organism, and the type and number of af-
fected organs adds further complexity to trialing within an already challenging patient
cohort. Some interventions, albeit based on a seemingly sound rationale, have even
been associated with patient harm.
It is starkly obvious that improving our still limited grasp of the underlying pathophysi-
ology is key to making major advances in patient management. Yet, basic/translational
research has been traditionally relegated to a minor role and is generally undervalued
by the clinical community. This is reflected by a relatively low profile at (inter)national
congresses, fewer funding opportunities, and comparatively few basic scientists specifically
focusing on critical care conditions and pathologies. Even the specialist journals generally
eschew basic/translational papers, particularly those involving animal or laboratory models.
However, in their defence, the quality of such work is somewhat variable, thus creating
a perfect Catch 22 situation of struggling to attract the funding and quality researchers
needed to improve the overall calibre of the research output.
With this in mind, Intensive Care Medicine, the official journal of the European Society
of Intensive Care Medicine (ESICM), has taken the bold step of splitting into two separate
but closely linked sister journals. Intensive Care Medicine will continue as a solely clinical
journal, reporting clinical trials, process of care, ethical issues, health economics, and so
forth. Intensive Care Medicine Experimental (ICMx) will focus on experimental research,
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The risk is that clinicians will choose to ignore this stand-alone offering. Yet, we hope
that offering a dedicated platform for such research will promote its importance, elevate
standards, improve transferability of findings from bench to bedside (and back), and
stimulate clinicians, basic scientists and, particularly, the next generations of researchers
to actively participate. In conjunction, other initiatives will be taken by ESICM to elevate
basic and translational research and encourage engagement.
Intensive Care Medicine Experimental (icm-experimental.com) will be an online-only
electronic journal that, by being open access, will guarantee rapid and widespread dissem-
ination of data, but with the assurance of decent, high-quality peer review [1]. Being part
of the SpringerOpen stable, it provides quality processing of manuscripts and numerous
portals to publicize the papers (including social media). This will be complemented by the
ESICM website that will promote the journal on its front page. A strong endorsement has
come from the ready acceptance by a cadre of 40 top-flight researchers to take on active
roles as Senior Editors and Editors, with commitments to lend their significant expertise
to the peer review process, to submit their research, and to offer enthusiastic promotion
in support of this fledgling journal. These researchers are a healthy mix of basic scientists
and clinician scientists whose research activities have led them to embrace experimental
research in distinct areas of critical care (inflammation, immunity, respiratory, metabolic,
neurological, endocrine, trauma, and so forth). ICMx will thus, uniquely, be driven by the
critical care community with a sole focus on basic to translational research.
As with any new offering, the first few years will be challenging. We are, however,
quietly confident that it will succeed and sincerely hope the scientific community will
join in this exciting journey.
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